Aug 30

PDF DOWNLOAD (Last Updated: Aug 18, 2023)

Track A @International Conference Hall, 3F

09:00-11:00
Session 3A1: Chemical Glycobiology
Chairs: Matthew Pratt, Chun-Cheng Lin
09:00
Keynote 1: Laurence Mulard, Pasteur Institute, France
Synthetic glycan-based vaccines to combat bacterial diseases: from concept to first-in-human data and beyond (D037)
09:30
Keynote 2: Xing Chen, Peking Univ., China (online presentation)
Labeling, imaging and proteomics of brain glycans (D038)
10:00
David Kwan, Concordia Univ., Canada
Controlling cellular sugar-coating to combat cancer (B006)
10:15
Yu Liu, Imperial College, UK
Glycosyltransferase engineering to dissect N-linked protein glycosylation (B008)
10:30
Thomas Haselhorst, Griffith Univ., Australia 
Discovery of new antifungals in the fight against invasive fungal infections (A154)
10:45
Cheng-I Yao, Academia Sinica, Taiwan 
Structural analysis of the lipid A from Parabacteroides goldsteinii (A079)

11:00-11:20
Coffee Break
@Lobby, 4F

11:20
Plenary 5: Matthew R Prat, Univ. of Southern California, USA
Build it to understand it: O-GlcNAc modification plays multiple protective roles against protein amyloid aggregation and pathogenesis (D008)
Chaired by: Todd Lowary

12:00-13:20
Lunch
@Communal area, 3F
Luncheon Seminar 3: Thermo Fisher Scientific
@Recreation Hall, 4F
Chaired by: Jeng-Shin Lee
Weijing Liu
Recent developments in the analysis of glycoproteins on orbitrap platforms

13:30-16:00
Session 3A2: Special Open Session on Chemistry and Synthesis for Glycobiology
Chairs: Cheng-Chung Wang, Jiun-Jie Shie
13:30
Keynote 1: Yasuhiro Kajihara, Osaka Univ., Japan
N-glycans on proteins (D039)
14:00
Keynote 2: Shang-Cheng Hung, Academia Sinica, Taiwan
Probing specific interactions of synthetic heparan sulfate saccharides and disease-related proteins (D040)
14:30
Carolin Neu, Martin-Luther Univ. Halle-Wittenberg, Germany
Ac3ManNAc-6-phosphoramidate prodrugs as potential new treatment for GNE myopathy (A113)
14:45
Eline Visser, Radbound Univ. Nijmegen, Netherlands
Studying metabolic inhibitors of glycosylation for potential therapeutic use (B013)
15:00
Mei-Ting Lin, National Tsing Hua Univ., Taiwan
Gram-scale chemoenzymatic synthesis of human milk oligosaccharides using crude cell lysate (B019)
15:15
Hsin-Kai Tseng, National Tsing Hua Univ., Taiwan
Substrates promiscuities of bacterial glycosyltransferases enable acceptor-mediated regioselective enzyme-catalyzed glycosylation (B046)
15:30
Mohammad Anwar, Academia Sinica, Taiwan
Chemoenzymatic synthesis of fluorophore-labelled K. pneumoniae O2a O-PS probes (B035)
15:45
Huang-Yi Li, Academia Sinica, Taiwan
Insights into dibasic iminosugars as pH-selective pharmacological chaperones to stabilize human α-galactosidase (B016)

Track B @2nd Conference Room, 3F

09:00-11:00
Session 3B1: Glycans in Cancer, Immunity and Infection
Chairs: Natalie Juge, Yung-Chi Chang
09:00
Keynote 1: Vered Padler-Karavani, Tel Aviv Univ., Israel
Glycans in immune recognition and response (D041)
09:30
Keynote 2: Mary Jackson, Colorado State Univ., USA
Molecular signals controlling the biosynthesis and biological activities of cell envelope (lipo)polysaccharides in Mycobacterium tuberculosis (D042)
10:00
Celso A Reis, Univ. of Porto, Portugal
Altered glycosylation in cancer affects cellular receptor tyrosine kinases and regulates cancer cell sensitivity to therapeutic drugs (A112)
10:20
Freda Jen, Griffith Univ., Australia
Targeting the glyco-achilles heel of Neisseria gonorrhoeae: A new strategy for vaccines to prevent Gonorrhea (A063)
10:40
Elisa Fadda, Maynooth Univ., Ireland
Changing the coat: Evolution of the SARS-CoV-2 S glycan shield and its role in modulating viral infection (A066)

13:30-15:30
Human Glycoproteomics Initiative Workshop
Coordinators: Morten Thaysen-Andersen, Daniel Kolarich, Kay-Hooi Khoo
Speakers and Panelists:
Morten Thaysen-Andersen, Macquarie Univ.; Stacy Malaker, Yale Univ.; Giuseppe Palmisano, Macquarie Univ.;
Online presentation:
Shisheng Sun, Northwest Univ.; Mingliang Ye, Chinese Academy of Sciences; Wen-Feng Zeng, Max Planck Institute